Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/6578| Title: | GLP 1 and SGLT2 Landscape- Approvals, Evidence, and Market Positioning Insights |
| Authors: | Singh, Muskan |
| Keywords: | GLP‑1 Receptor Agonists SGLT2 Inhibitors Type 2 Diabetes Mellitus (T2DM) Health Technology Assessment (HTA) Cost‑Effectiveness Cardiovascular Outcomes Market Access Empagliflozin Semaglutide Tirzepatide |
| Issue Date: | 2026 |
| Publisher: | IIHMR University, Jaipur |
| URI: | http://localhost:8080/xmlui/handle/123456789/6578 |
| Appears in Collections: | 2026 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Muskan Singh-D.pdf | Dissertation Report | 1.41 MB | Adobe PDF | Preview PDFDownload |
| Muskan Singh-IR.pdf | Internship Report | 155.01 kB | Adobe PDF | Preview PDFDownload |
| Muskan Singh-P.pdf | Presentation | 424.36 kB | Adobe PDF | Preview PDFDownload |
| Muskan Singh-S.pdf | Synopsis | 162.61 kB | Adobe PDF | Preview PDFDownload |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.